$61.40
0.871.44%
At close: -
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Sector
Healthcare
Region
US
AUM
21.41M
Fund Score
Virtus LifeSci Biotech Products ETF (ARCA:BBP) Quotes, Forecast and News Summary
Virtus LifeSci Biotech Products ETF (ARCA: BBP) stock price, news, charts, stock research, profile.
| Open | $61.08 |
| High | $61.40 |
| 52 Wk High | $69.12 |
| AUM | 21.41M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 735 |
| Market Cap | $19.92B |
| Mgmt Fee | 0.79% |
| P/E Ratio | 14.96 |
| Prev. Close | $60.53 |
| Low | $61.08 |
| 52 Wk Low | $48.50 |
| Shares Out | 350.00K |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 3.29K |
| Beta | 0.63 |
| Avg. Expense Ratio | 0.79% |
| P/B Ratio | 4.03 |
Recent News
FAQ
Q
How do I buy Virtus LifeSci Biotech Products ETF (BBP) stock?
A
You can purchase shares of Virtus LifeSci Biotech Products ETF (ARCA:BBP) through any online brokerage.
Q
Who are Virtus LifeSci Biotech Products ETF (BBP) competitors?
A
There are no as such competitors for Virtus LifeSci Biotech Products ETF.
Q
What is the forecast, or price target, for Virtus LifeSci Biotech Products ETF (BBP) stock?
A
There is no analysis for Virtus LifeSci Biotech Products ETF to provide a consensus price target.
Q
What is the current price for Virtus LifeSci Biotech Products ETF (BBP)?
A
The stock price for Virtus LifeSci Biotech Products ETF (ARCA: BBP) is $53.29 last updated April 29, 2024 at 7:03 AM EDT.
Q
Does Virtus LifeSci Biotech Products ETF (BBP) pay a dividend?
A
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2017 to stockholders of record on December 20, 2017.
Q
When is Virtus LifeSci Biotech Products ETF (ARCA:BBP) reporting earnings?
A
Virtus LifeSci Biotech Products ETF does not have any upcoming earnings scheduled.
Q
Is Virtus LifeSci Biotech Products ETF (BBP) going to split?
A
There is no upcoming split for Virtus LifeSci Biotech Products ETF.
| Open | $61.08 |
| High | $61.40 |
| 52 Wk High | $69.12 |
| AUM | 21.41M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 735 |
| Market Cap | $19.92B |
| Mgmt Fee | 0.79% |
| P/E Ratio | 14.96 |
| Prev. Close | $60.53 |
| Low | $61.08 |
| 52 Wk Low | $48.50 |
| Shares Out | 350.00K |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 3.29K |
| Beta | 0.63 |
| Avg. Expense Ratio | 0.79% |
| P/B Ratio | 4.03 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Dec 16, 2014 |
| Managers | Seth Kadushin Matthew B. Brown Andrew McDonald Paul Yook |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| ADMA | Adma Biologics Inc Com | 4.54% |
| INSM | Insmed Inc | 3.66% |
| TARS | Tarsus Pharmaceuticals... | 3.31% |
| MRNA | Moderna therapeutics | 3.19% |
| DCPH | Deciphera Pharmaceutic... | 3.10% |
| AGIO | Agios Pharmaceuticals ... | 3.01% |
| SRPT | Sarepta Therapeutics I... | 2.64% |
| PTCT | Ptc Therapeutics Inc | 2.53% |
| LXRX | Lexicon Pharmaceutcl | 2.51% |
| BPMC | Blueprintmedicines Cor... | 2.42% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved